NCT02303821 2025-06-04
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Amgen
Phase 1 Completed
Amgen
Chongqing Peg-Bio Biopharm Co., Ltd.
Dana-Farber Cancer Institute
University of Miami
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center